Analyzing Legend Biotech Corp ADR (LEGN)’s quick and current ratios

Legend Biotech Corp ADR (NASDAQ: LEGN) closed the day trading at $64.22 up 0.69% from the previous closing price of $63.78. In other words, the price has increased by $+0.44 from its previous closing price. On the day, 791635 shares were traded.

Ratios:

For a better understanding of LEGN, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.51 and its Current Ratio is at 8.61. In the meantime, Its Debt-to-Equity ratio is 0.24 whereas as Long-Term Debt/Eq ratio is at 0.24.

On November 06, 2023, Goldman started tracking the stock assigning a Buy rating and target price of $90.09.

On May 25, 2023, William Blair started tracking the stock assigning a Mkt Perform rating and target price of $64.William Blair initiated its Mkt Perform rating on May 25, 2023, with a $64 target price.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LEGN now has a Market Capitalization of 11.71B and an Enterprise Value of 10.60B. Its current Enterprise Value per Revenue stands at 45.45 whereas that against EBITDA is -22.66.

Stock Price History:

Over the past 52 weeks, LEGN has reached a high of $77.32, while it has fallen to a 52-week low of $42.90. The 50-Day Moving Average of the stock is 59.82, while the 200-Day Moving Average is calculated to be 65.25.

Shares Statistics:

Over the past 3-months, LEGN traded about 909.35K shares per day on average, while over the past 10 days, LEGN traded about 769.22k shares per day. A total of 181.79M shares are outstanding, with a floating share count of 180.01M. Insiders hold about 0.98% of the company’s shares, while institutions hold 46.99% stake in the company. Shares short for LEGN as of Feb 15, 2024 were 9.94M with a Short Ratio of 10.93, compared to 10.01M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 5.45% and a Short% of Float of 10.46%.

Earnings Estimates

Current recommendations for the stock of the company come from 4 analysts. On average, analysts expect EPS of -$0.83 for the current quarter, with a high estimate of -$0.5 and a low estimate of -$1.48, while EPS last year was -$1.24. The consensus estimate for the next quarter is -$0.62, with high estimates of -$0.62 and low estimates of -$0.63.

Analysts are recommending an EPS of between -$1.19 and -$4.68 for the fiscal current year, implying an average EPS of -$2.72. EPS for the following year is -$2.14, with 9 analysts recommending between -$0.86 and -$5.7.

Revenue Estimates

A total of 17 analysts have provided revenue estimates for LEGN’s current fiscal year. The highest revenue estimate was $500M, while the lowest revenue estimate was $282M, resulting in an average revenue estimate of $311.19M. In the same quarter a year ago, actual revenue was $117M, up 166.00% from the average estimate. Based on 17 analysts’ estimates, the company’s revenue will be $581.02M in the next fiscal year. The high estimate is $704.5M and the low estimate is $476.2M. The average revenue growth estimate for next year is up 86.70% from the average revenue estimate for this year.

Most Popular

[the_ad id="945"]